On the other hand, our model did not show maternal metabolic alterations other than an increased fat mass because we aimed to avoid the effects of hyperglycemia and elevated insulin levels on placental function; therefore, this allows us to attribute our findings to dietary effects and maternal adiposity rather than to metabolic disturbances associated with glucose metabolism. The gene discussed is INS; the disease is Hyperglycemia.